Ortho Regenerative Technologies (ORTIF) Stock Price, News & Analysis

Company Overview

Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.

Key Stats

• Today's Range: $0.20 to $0.20
• 50-Day Range: $0.20 to $0.20
• 52-Week Range: $0.13 to $0.45
• Volume: N/A
• Average Volume: 3,282 shs
• Market Capitalization: $6.86 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ORTIF Stock Analysis - Frequently Asked Questions

How have ORTIF shares performed this year?

Ortho Regenerative Technologies' stock was trading at $0.1962 at the beginning of 2025. Since then, ORTIF shares have increased by 0.0% and is now trading at $0.1962.
View the best growth stocks for 2025 here.

How do I buy shares of Ortho Regenerative Technologies?

Shares of ORTIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 6/21/2025
• Fiscal Year End: 1/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical Appliances & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ORTIF
• CIK: N/A
• Web: www.orthorti.com
• Phone: (514) 782-0951
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.93 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -269.68%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.26
• Quick Ratio: 1.26

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.16) per share
• Price / Book: -1.23

Miscellaneous

• Outstanding Shares: 34,956,000
• Free Float: N/A
• Market Cap: $6.86 million
• Optionable: Not Optionable
• Beta: -1.16